Medline Inc.
NASDAQMDLN short interest tumbled 24.4% in one week to 28.2M shares, though availability remains abundant at 243.6% of SI, keeping short costs minimal at 0.69%.
MDLN heads into its August 5 earnings date riding a sharp one-month rally, but options traders have swung decisively toward downside protection, creating a notable tension between price momentum and hedging…
Medline Inc. enters its June 11 earnings date carrying a striking new development: its private equity backers just sold over $2.3 billion worth of stock, and the short sellers who dominated the prior week's story have…
Snapshot as of 6 Aug 2026
Medline Inc. heads into its June 11 earnings date with short interest at a new high, the stock down sharply on the month, and a Street that remains broadly bullish but increasingly cautious on near-term execution. The…
Medline Inc. enters the week of May 18 with a striking divergence: short interest has extended its rebuild to a new recent high, while options traders have turned notably more bullish than at any point in the past…
Medline Inc. heads into the week of May 14 with shorts rebuilding, analysts trimming targets, and the stock nursing its worst two-week stretch since listing. The clearest story this week is in short positioning. Short…
MDLN drops its Q1 2026 results on May 8 carrying a 7% one-day loss, a pile of private equity selling, and options positioning that has shifted notably more defensive. The session before the print told a stark story.…
MDLN delivered a clean Q1 beat this morning — EPS of $0.33 against a $0.23 estimate, and revenue of $7.4 billion clearing the $7.16 billion consensus — yet the same day brought a potentially more disruptive headline:…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MDLN — free to start on ORTEX.
Sign up for free →Open MDLN on ORTEX